Australia

Fingolimod-Teva

 

Flingolimod 400x400

Fingolimod-Teva® is indicated for the treatment of adult and paediatric patients of 10 years of age and above with relapsing forms of multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.

Patient Parent Carer Guide

Learn more

Physicians Checklist

Learn more

Pregnancy Reminder Card

Learn more
PBS Information: Authority Required
Refer to PBS Schedule for full authority information

PLEASE REVIEW PRODUCT INFORMATION (PI) BEFORE PRESCRIBING.
Full PI can be accessed at https://rss.medsinfo.com.au/tb/pi.cfm?product=tbpfingo10123 or from Medical Information on 1800 AU TEVA (1800 288 382).

Date of preparation: May 2023, May 2023, GX-AU-00002.